Related Experiment Video
Updated: Mar 2, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Specialized pro-resolving mediators in renal fibrosis
Eoin P Brennan1, Antonino Cacace1, Catherine Godson1
1UCD Diabetes Complications Research Centre, UCD Conway Institute & UCD School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland.
Specialized pro-resolving lipid mediators (SPMs) help resolve inflammation and may prevent fibrosis. This review explores how SPMs offer novel therapeutic strategies for fibrotic diseases like kidney fibrosis.
Area of Science:
- Biomedical Science
- Molecular Biology
- Immunology
Background:
- Inflammation is crucial for host defense and wound healing.
- Unresolved inflammation causes tissue fibrosis and organ failure (e.g., kidney, lung, liver).
- Autocrine/paracrine mediators like cytokines sustain inflammation.
Purpose of the Study:
- To review the role of specialized pro-resolving lipid mediators (SPMs) in inflammation.
- To explore the potential of SPMs in resolving inflammation and preventing fibrosis.
- To discuss therapeutic applications of SPMs for fibrotic diseases.
Main Methods:
- Literature review of studies on SPMs and fibrosis.
- Analysis of the mechanisms by which SPMs modulate inflammatory responses.
- Examination of evidence for direct anti-fibrotic effects of SPMs.
Main Results:
- SPMs are increasingly recognized for their role in resolving inflammation.
- SPMs attenuate fibrosis by promoting inflammation resolution.
- SPMs may also possess direct anti-fibrotic properties.
Conclusions:
- SPMs represent a novel therapeutic target for fibrotic diseases.
- Targeting SPMs could offer new treatment paradigms for conditions like renal fibrosis.
- Further research into SPM mechanisms may unlock innovative therapies.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care

